chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Nurse administered Menactra vaccine to patient.  Nurse left room to obtain vaccine card for patient to keep.  Was gone approximately one minute and on the way back to the patient room she heard a thump.  Patient had passed out and was lying on the floor.  He was coming to as she entered the room.  Patient had visible area on forehead where he had fallen and hit it.  The physician was notified and examined patient.  Patient was kept at clinic approximately 45 minutes and vitals were monitored.  He was examined again by the nurse practitioner before leaving the clinic.
Patient developed a fever the morning after receiving her flu and pneumovax vaccines. Patient noticed swelling around injection site for pneumonia vaccine, and eventually around 4 PM the following day red welts developed and wrapped around the whole arm for an area of 3 by 6 inches. Patient temperature was 100.6 degrees fahrenheit last night at 6 PM on the 28th. Redness in area has spread this morning but is less painful. Patient is monitoring situation and will follow up with MD on Monday. MD at medical clinic
unable to sleep (days 2-5 post-vaccine), 3x5" rash appeared at site of injection 10 days post-vaccine on 4/13 (mild itching, raised skin, warm to touch),  isolated nighttime enuresis incident 11 days post-vaccine 4/14
Walking pneumonia; This case was reported by a consumer via interactive digital media and described the occurrence of walking pneumonia in a female patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season at an unknown dose. On an unknown date, 3 days after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced walking pneumonia (serious criteria GSK medically significant). On an unknown date, the outcome of the walking pneumonia was unknown.   It was unknown if the reporter considered the walking pneumonia to be related to Influenza vaccine Quadrivalent unspecified season.  Additional details were provided as follows: The case was reported by patient's daughter. The age at vaccination was not reported. The patient experienced walking pneumonia after receiving Flu vaccine. It was reported that, the doctors said same thing it was a coincidence. The reporter felt that the doctors were lying through their teeth. As far as the whooping cough was concerned, the people were being injected then shedding the vaccine. It was reported that, if the reporter was obviously coughing and knew was sick, I would not be around a baby, or an elderly person. It was reported that, when you were vaccinated, there may be no symptoms, until had been already infected by another person. This is 1 of the 3 cases reported by the same reporter.
FOLLOWING VACCINE APPROX ONE-HALF HOUR DIZZINESS UNTIL EVENING PROGESSED TO NAUSEA  THAT EVENING BAD HEADACHE NIGHT SWEATS  CONTINUED FOR 48 HOURS  PATIENT TOOK TYLENOL 2 TABLET  (1000MG) WHICH HELPED HEADACHE THEN WED FELT IMPROVED BUT HAS HAD CONTINUED DAILY EPISODES OF LIGHTHEADEDNESS AND "FOGGY" BRAIN FEELING  tHIS IS CONTINUING AT THIS TIME
Headache, Chills, Fever, and Difficulty keeping awake. Treatment: Tylenol and Ibuprofen
Swelling from shoulder to elbow. No hives or fever. Pt states swelling has gone down some but did want to let us know she had a reaction. Pt using ice pack, benadryl, motrin/and tylenol
This spontaneous report was received from a registered nurse regarding a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 13-JAN-2017, 15-MAR-2017 and 28-MAR-2017, the patient was vaccinated with ROTATEQ, orally, for prophylaxis (dose number, lot # and expiration date were unknown) (product use issue). No adverse symptoms were reported. Additional information has been requested.
After about 15 min of administration patient had tightening and soreness of the throat and itching all over her body. Patient was given oral Benadryl  and stable after about 10 min with no worsening of symptoms but little improvement. Patient advised to see medical attention.
BRUISING; FREEZING; PERSISTENT SORENESS; NAUSEOUS; HEADACHE; DIZZINESS; LIGHTHEADEDNESS; THROBBING; DIDNOT SLEEP LAST NIGHT; This spontaneous report received from a patient concerned a 49 year old female. The patient's height, and weight were not reported. The patient's past medical history included hysterectomy, migraines, blood transfusion-anemia, and FE infusion, and concurrent conditions included abstains from alcohol, cigarette smoker, penicillin allergy, and epilepsy keppra cause plaque psoriasis, and other pre-existing medical conditions included patient did not drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978, expiry: UNKNOWN) dose was not reported, administered on 31-MAR-2021 14:00 on right arm for prophylactic vaccination. No concomitant medications were reported. On 31-MAR-2021, the subject experienced throbbing. On 31-MAR-2021, the subject experienced lightheadedness. On 31-MAR-2021, the subject experienced did not sleep last night. On 31-MAR-2021, the subject experienced dizziness. On 31-MAR-2021, the subject experienced nauseous. On 31-MAR-2021, the subject experienced headache. On 01-APR-2021, the subject experienced persistent soreness. On 01-APR-2021, the subject experienced freezing. On an unspecified date, the subject experienced bruising. Treatment medications (dates unspecified) included: acetylsalicylic acid/caffeine/paracetamol/salicylamide, diazepam, and famotidine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from lightheadedness, dizziness, and headache on 01-APR-2021, was recovering from nauseous, had not recovered from persistent soreness, throbbing, and freezing, and the outcome of didnot sleep last night and bruising was not reported. This report was non-serious.
I had an injection of ZOSTAVAX on 03/25/2009 about six days later developed red spots on my right leg on the inside between ankle and knee.  The spots numbered about twenty.  These spots did have small pockets of infection.  I went back to my medical doctor on 04/07/2009 and he confirmed that I possibly had a minor case of shingles.  These blotches did not itch or hurt.  I never had shingles in the past.
PT HAD COVID MAY OR JUNE; Medication: PFIZER COVID VACCINE/ (Infection); This is a spontaneous report received from contactable reporter(s) (Other healthcare professional and Consumer or other non healthcare professional) for a program (054550).  A 43 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported DRUG INEFFECTIVE (hospitalization, medically significant) with onset 2021, outcome recovered; COVID-19 (hospitalization, medically significant) with onset May/June 2021, outcome recovered. The patient was hospitalized for drug ineffective, covid-19 (hospitalization duration: 5 day(s)).  No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected. Based on available information a contributory role of BNT162B2 to the reported events Covid-19 and Drug ineffective cannot be totally excluded as efficacy of a drug varies from individual to individual depending upon the immune status. As with any vaccine, vaccination with BNT162B2 may not protect all vaccine recipients, so the expectedness of covid-19 and drug ineffective is expected. The case will be reassessed further upon receipt of additional information.
major: neurologic effects upon waking - feeling of brain ricocheting back and forth upon change in position  minor - chills & feverishness
Patient broke out in hives the evening of the vaccination. She has suffered from hives in the past but the vaccine exacerbated them quite a bit. She had hives on a majority of her body as well as localized to the injection site. She had a hive at the site of injection about the size of a quarter.
Information has been received from a registered nurse referring to unspecified patients of unknown ages and genders. Since October 2014 the patients were vaccinated with doses of improperly stored VAQTA (route, lot#, dose and frequency were unknown). No adverse effects were noted. It was unspecified if the patients sought medical attention. This is one of the several reports received from the same reporter. Additional information has been requested.
rash on the lower inner arm; Initial information received on 28-Feb-2020 regarding an unsolicited valid non-serious case received from a nurse.  This case is linked to case 2020SA055799 (same reporter).  This case involves a patient of unknown demography who experienced rash on the lower inner arm (rash), while he/she received vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV].  Medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE lot number not reported via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious rash on the lower inner arm (rash) (unknown latency) following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE.  Laboratory data was not reported.  Final diagnosis was rash.  It was not reported if the patient received a corrective treatment.  The patient had recovered from the event on an unknown date.  Information on the batch number was requested.
a 5 year old received dose number 2 and dose number 3 in the series approximately 6weeks and 5 days apart; This spontaneous report was received from a physician referring to a 5-year-old patient of unknown gender.  The patient's medical history, concurrent condition and drug reactions or allergies were not reported.      On unknown dates, the patient received dose number 2 and dose number 3 of hepatitis b vaccine (recombinant) (RECOMBIVAX HB) intramuscularly (dose, strength, frequency, lot number and expiration date were unknown) for hep B prevention in the series approximately 6 weeks and 5 days apart (inappropriate schedule of product administration). No lab diagnostics/studies were performed.
developed new onset hypothyroidism, bilateral pleural effusions, and congestive heart failure from diastolic failure
My temperature was low very low but sweating my hand where ice that was from second shot and continued until my chest started to hurt. My health got worse after the shots, I got really sick in November. I thought nothing of it but to go back work I had to the coronavirus test, well the doctor heard my heart was irregular heart beat. She called my normal doctor left her a message. I saw my normal three days later she heard it.
Patient contracted COVID after being fully vaccinated. fever, congestion, runny nose, sneezing, cough, sore throat, chills, fever, fatigue, loss of taste.
No adverse events. Wellness nurse inadvertently administered a 0.5mL dose of Fluarix (GSK) to a 19 month old before realizing that the vaccine was only licensed for use in people age 3 years and older.
Mother reports patient had a headache shortly after vaccination. Lasted for 5 days. Never had headaches before. Treated with OTC regimen. Has not needed additional medical care. Involved entire head. No nausea/vomiting/fever. No illness. Did receive Tdap at the same time.
Soreness in arm; Intense burning in arm; Chills; Overall body weakness; Extreme muscle soreness; Lack of strength; Headaches; This is a spontaneous report from a non-contactable consumer, the patient. A 21-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 12May2021 in the morning (at the age of 21-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12May2021, post vaccination in the morning, the patient immediately noticed soreness which gradually increased throughout the day. By the evening, arm was so sore that she could barely move her arm and when did so, she experienced intense burning and pain. She also experienced chills and overall body weakness which she understood was to be expected. However, she realized that the extreme muscle soreness and lack of strength she experienced was rare and which was why she felt compelled to report this. Additionally, since she had received the vaccine, she had noticed an increase in headaches. The patient prayed for healing. On 13May2021, by morning, her arm was only mildly sore and she felt normal a couple of days later. Therapeutic measures were taken as a result of events and included treatment with ibuprofen pills and iced her shoulder. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The clinical outcome of the event headaches was not resolved. The clinical outcome of the events soreness in arm, intense burning in arm, chills, overall body weakness, extreme muscle soreness and lack of strength was recovered on an unknown date in 2021.   No follow-up attempts are possible. No further information is expected.
pt recv vax 27MAY94 & 29MAY94 pt devel diarrhea; No further details were provided;
Employee contacted Employee Health on 01/05/2021 after receiving COVID vaccine #1 complaining of cough, sinus headache, redness and streaking across eyelids, congestion, facial swelling that spread down her cheeks and chin area - took OTC Benadryl, fell asleep, and when she awaken, swelling to face had worsened - went to ER
Systemic: Confusion-Mild, Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Mild, Systemic: Weakness-Mild
I am breastfeeding. I experienced Mastitis to right breast after right arm injection with abnormal discharge, redness and pain to breast, fever, chills, elevated heart rate, and body aches. Exacerbated inflammation as compared to previous dose (10/2022 which had redness and pain with plugged ducts but no fever).  Antibiotics prescribed x10d
A Fib - starting ? date April. [May 28, 2022 & saw substitute Dr. who said heart sounded OK] continued to worsen & by Nov 8, 2022 Dr EKG abnormal & referred to Heart Dr. ECG done & Stress test done 12/8/22
HYPOXIA 1/20/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
No additional adverse effects were reported in the patient; patient received a dose of VARIVAX following a temperature excursion; This spontaneous report was received from a medical assistant, referring to patient of unknown age and gender. The patient's pertinent concurrent conditions, pertinent medical history, concomitant medications and previous drugs reactions or allergies were not provided.  On an unspecified date in January 2020, the patient was vaccinated with an improperly stored varicella virus vaccine live (oka/merck)(VARIVAX)  (concentration, number of administered dose, vaccination scheme frequency, route and anatomical location of vaccination were not reported; lot number S024369 has been verified to be a valid, expiration date reported and validated as 08-JUN-2021) as prophylaxis. No adverse effects were reported for the patient.  According to the reporter, the temperature excursion was between 6 degrees Fahrenheit to 14 degrees Fahrenheit (-14 degrees Celsius to -10 degrees Celsius) (9.8 degrees Fahrenheit) for a time frame of two hours on an unspecified date (product storage error), without any previous temperature excursion; which was detected by a digital data logger.
around 1030AM on 19JUN96 mom noted pt had t102.8 & whole body was shaking, was playing then suddenly started crying then started shaking & could hardly breathe;eyes rolled up;lasted approx 2min;then off & on some shaking until reaching hosp
About 15 minutes after receiving the vaccine she felt palpitations. She was monitored for another 15 minutes and while she was walking to her car se started noticing sore throat associated with inability to talk, unable to swallow secretions,  and swelling the lips. Patient presented to the emergency room where she received EpiPen dose. Received diphenhydramine, famotidine, and prednisone.  Lip swelling and sore throat began improving in ED.
Pt comes into office 12/07/06. Left side of face and jaw swollen since this am. Pt received ProQuad and Hep A and 2nd flu shot on 11/17/06. DC Parotitis. Presumably 2 hours to  ProQuad.
cannot raise arm; itching; sore arm; aches everywhere; bad headache; fever over 101°F; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (cannot raise arm), PRURITUS (itching), PAIN IN EXTREMITY (sore arm), PAIN (aches everywhere) and HEADACHE (bad headache) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced LIMB DISCOMFORT (cannot raise arm), PRURITUS (itching), PAIN IN EXTREMITY (sore arm), PAIN (aches everywhere), HEADACHE (bad headache) and PYREXIA (fever over 101°F). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, LIMB DISCOMFORT (cannot raise arm), PRURITUS (itching), PAIN IN EXTREMITY (sore arm), PAIN (aches everywhere), HEADACHE (bad headache) and PYREXIA (fever over 101°F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 (High) 101°F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included birth control pill.
Swelling, itchy rash, mild redness on the arm where the vaccine is injected
Moderna COVID-19 Vaccine EUA Itch and then rash, espcially near anus/genital. When first began I had to take a shower and it was the middle of the night. This morning (5/10/2021) at 6:30 AM genital area was red/rashy and slightly itch. I also had a slight itch on back and torso. Slight rash near underarms of both arms. I applied some body lotion and that eased the itch.
PT CAME IN TODAY, DECEMBER 30TH (2 DAYS AFTER RECEIVING VACCINE) AND SAID HE HAD QUESTIONS ABOUT THE SHOT HE HAD GOTTEN. HE STATED THAT LATER THE SAME DAY AS RECEIVING THE VACCINE HIS ARM TURNED RED AND WAS SWOLLEN "THREE SIZES LARGER THAN NORMAL". I LOOKED AT HIS ARM TODAY AND THERE IS A RED SWOLLEN AREA ON THE INSIDE OF HIS RIGHT ARM AND HE SAID THE AREA HAD BEEN SPREADING DOWN HIS ARM TOWARD HIS HAND BUT WAS BETTER THAN IT WAS. I ASKED THE PT IF HE HAD A NORMAL DOCTOR BUT HE DOES NOT; I TRIED CALLING THE MERCK VACCINE HOTLINE BUT THEY ARE CLOSED UNTIL AFTER THE NEW YEAR'S HOLIDAY. INSTRUCTED THE PT HE COULD TAKE SOME IBUPROFEN OR TYLENOL IF NEEDED BUT IF IT GOT ANY WORSE TO GO TO THE LOCAL WALK IN CLINIC. I ALSO TOLD THE PT I WOULD CALL MERCK WHEN THEY OPEN BACK UP ON JANUARY 2ND AND GIVE HIM A CALL TO CHECK ON HIM.
On 10/22/12 pt stated her arm (L) was swollen, sore, red and warm to touch. She also stated that she felt a lump. She tried taking IBU which helped with pain some but she went to MD on 10/24 and received steroid and antibiotic Rx for cellulitis.
Bell's Palsy w/in 2wk of vax;no other etiology;
Vaccine Administered 9:30 AM Nov 28 Developed sore throat, cough, and headache two hrs later. Condition worsened during day. Experienced intermittent pain in neck, arms, legs. Developed red rash on buttocks.  Applied anti itch ointment, and antibiotic cream. No benefit. Condition same Nov29. Took 50 mg Benadryl every 4 hrs. Took two Tyanol. Condition about same on Nov 30 Slight improvment in headache, no change in rash, cough, and sore throat. Neck pain continues
Information has been received from a consumer concerning her daughter who on an unspecified date was vaccinated with a dose of ATTENUVAX, a dose of of MERUVAX, and  a dose of MUMPSVAX.  Subsequently the patient experienced high fever.  This is one report of several from the same source.  Additional information has been received from an unspecified source who stated that a patient can not be identified. Additional information has been requested.
Mother reported child woke up in the middle of the night with a fever (mother reports that they did not take a temp as they didn't have a thermometer at home).  Arms felt cramped.  No redness or swelling at sight of injection.  Denies any other s/s.  Child was at home when parent called.
Headache; nausea; Body Aches; chills; Really Tired for 2 days; Injection Site hurt worse and for longer period; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 15Apr2021 at 10:00 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included thyroid (ARMOUR THYROID) and cimicifuga racemosa (BLACK COHOSH); both taken for unknown indications from unknown start dates and unknown if ongoing. The patient previously received codeine (MANUFACTURER UNKNOWN) on unknown dates for an unknown indication and experienced drug allergy. The patient also previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on an unspecified date (also reported as Mar2020) at 10:00 as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19.  On 16Apr2021, after the second vaccination, the patient experienced headache, nausea, body aches, chills, really tired for 2 days, and injection site hurt worse and for a longer period. However, the patient rated this as mild. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care visit. Therapeutic measures were not taken as a result of reported events. The clinical outcome of the event really tired was recovered on 18Apr2021 after the duration of 2 days.  The clinical outcomes of the headache, nausea, body aches, chills and injection site hurt worse were recovered on an unspecified date in Apr2021.   No follow-up attempts are needed. No further information is expected.